SCHEMBL15973108

SCHEMBL15973108

CC(=O)N[C@H]1[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@@H](COCc2ccccc2)O[C@@H]1CP(=O)(O)O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.55
▸ MDM2 Q00987 2/20 0.55
▸ MDM4 O15151 1/20 0.50
▸ HSP90AA1 P07900 1/20 0.50
▸ HSP90AB1 P08238 1/20 0.50
▸ TACR2 P21452 3/20 0.45
▸ NT5E P21589 1/20 0.45
▸ BCHE P06276 1/20 0.45
▸ PTPN1 P18031 6/20 0.42
▸ CDC25B P30305 5/20 0.42
▸ LMNA P02545 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SSTR4 P31391 1/20 0.42
▸ PDPK1 O15530 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ PTPN2 P17706 2/20 0.41
▸ PTPN6 P29350 2/20 0.41
▸ PTPN11 Q06124 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15973107 1.00 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL12127990 0.92 LMNA (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL1339011 0.92 LMNA (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL17363573 0.89 TP53 (0.51) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL13296098 0.88 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL24378386 0.86 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL15516519 0.86 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL5840884 0.86 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL15514084 0.86 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL13296075 0.86 TP53 (0.57) TP53MDM2MDM4HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2958905-B1 CARBOHYDRATE PHOSPHONATE DERIVATIVES AS MODULATORS OF GLYCOSYLATION AMGEN INC (US) 2017-03-29 — — EP disclosed
US-9328134-B2 Carbohydrate phosphonate derivatives as modulators of glycosylation AMGEN INC. (US) 2016-05-03 — — US disclosed
US-20150376221-A1 Carbohydrate Phosphonate Derivatives as Modulators of Glycosylation AMGEN INC. 2015-12-31 — — US disclosed
EP-2958905-A2 CARBOHYDRATE PHOSPHONATE DERIVATIVES AS MODULATORS OF GLYCOSYLATION Amgen Inc. (US) 2015-12-30 — — EP disclosed
WO-2014130613-A2 CARBOHYDRATE PHOSPHONATE DERIVATIVES AS MODULATORS OF GLYCOSYLATION AMGEN INC. (US) 2014-08-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376221-A1 Carbohydrate Phosphonate Derivatives as Modulators of Glycosylation GALE, GPI, FUT6 TP53 2322/4885MDM2 4478/4885MDM4 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback